title: [Cardiogenic shock complicating acute myocardial infarction: trends in management and outcome].
abstract: Despite emergency coronary revascularization coupled with medical stabilization, intra-aortic balloon pump and ventricular assist devices have significantly improved survival in patients with cardiogenic shock complicating acute myocardial infarction, mortality still remains excessively high, being actually about 30-40%. Future research should focus on new therapeutic strategies, aimed to further decrease mortality rate of these patients.
authors.affiliation: Centro Cardiologico Monzino, I.R.C.C.S., Dipartimento di Scienze Cardiovascolari, Università di Milano. marco.grazi@ccfm.it
authors.forename: Marco
authors.initials: M
authors.lastname: Grazi
authors.forename: Stefania
authors.initials: S
authors.lastname: Farina
authors.forename: Emilio
authors.initials: E
authors.lastname: Assanelli
mesh_terms: D017130:Angioplasty; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D003422:Critical Care; D004562:Electrocardiography; D005544:Forecasting; D006353:Heart-Assist Devices; D006801:Humans; D007423:Intra-Aortic Balloon Pumping; D009203:Myocardial Infarction / Q000150:complications* / Q000175:diagnosis / Q000601:surgery; D009204:Myocardial Revascularization; D016032:Randomized Controlled Trials as Topic; D012770:Shock, Cardiogenic / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery / Q000628:therapy*; D013566:Sympathomimetics / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D002316:Cardiotonic Agents; D013566:Sympathomimetics